001367.SZ · 海森药业
China A-shares · RS rating 78 · As of 2026-10-14
| Price | 20.77 CNY |
|---|---|
| 1-day change | -1.5% |
| RS rating (overall / 1M / 3M / 12M) | 78 / 82 / 79 / 52 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 41 / 37 / 14 |
| Industry group (rank) | Medical-Products (64) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | +34.0% |
| Distance from 52-week high | +24.2% |
| Market cap (USD) | $496.0M |